Yesterday's Financial Times reported that pharmacists in Spain are struggling to continue operating their businesses due to a lack of payment from the Regional governments. “We depend 80 to 90…
GSK announced that it has taken a ~25% stake in a new spin out. This is a terrific way to create new companies and advance more molecules into the clinic,…
On the one hand, you hate to see talent leaving the US. But, you have to applaud their attitude: "Although we are comfortable in America, we often felt that something…
Posts have been light lately, due to vacations, summer hours, etc. However, we've remained busy with client work and keeping up with the news. A few recent news items of…
Today's New England Journal of Medicine contains a short article by Kozlowski et al entitled Developing the Nation's Biosimilars Program (link to PDF). Here, the authors attempt t provide a…
As we were wrapping up our annual July vacation, we were shocked to hear about the magnitude of job cuts at Merck. This is on top of the 11,500 jobs Merck cut…
As FiercePharma correctly points out, GSK's Q II report reflects the overall industry trends quite accurately: The rest of Glaxo's report, like the rest of Big Pharma's Q2 results so…
Today, KPMG is reporting results from a survey of pharmaceutical executives. In this survey, respondents said they will increase their acquisition activity in the coming year in order to gain…
Luke Timmerman at Xconomy wrote a provocative piece today entitled The Missing Ingredient in Today's Biotech: Guts. His thesis is that the industry is so paralyzed by fear and insecurity that it lacks…
We previously posted our comments on BIO 2011. However, one aspect of the conference that really stood out was the use of social media. Attendees were encouraged to provide links…